A detailed history of Hotaling Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hotaling Investment Management, LLC holds 23,601 shares of ABBV stock, worth $3.96 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares
23,601
Previous 23,526 0.32%
Holding current value
$3.96 Million
Previous $3.16 Million 20.81%
% of portfolio
1.72%
Previous 1.51%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $10,373 - $12,440
75 Added 0.32%
23,601 $3.81 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $56,233 - $64,496
419 Added 1.81%
23,526 $3.16 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $149,592 - $190,181
1,087 Added 4.94%
23,107 $3.54 Million
Q1 2022

Apr 22, 2022

BUY
$131.98 - $163.75 $615,818 - $764,057
4,666 Added 26.89%
22,020 $3.57 Million
Q4 2021

Jan 24, 2022

SELL
$107.43 - $135.93 $2,793 - $3,534
-26 Reduced 0.15%
17,354 $2.35 Million
Q3 2021

Oct 21, 2021

BUY
$106.4 - $120.78 $36,601 - $41,548
344 Added 2.02%
17,380 $1.88 Million
Q2 2021

Aug 04, 2021

BUY
$105.21 - $117.21 $1.37 Million - $1.53 Million
13,067 Added 329.23%
17,036 $1.92 Million
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $10,230 - $11,262
-100 Reduced 2.46%
3,969 $429,000
Q4 2020

Jan 22, 2021

SELL
$80.49 - $108.67 $2,012 - $2,716
-25 Reduced 0.61%
4,069 $436,000
Q3 2020

Nov 04, 2020

SELL
$85.91 - $100.83 $634,445 - $744,629
-7,385 Reduced 64.33%
4,094 $359,000
Q2 2020

Jul 31, 2020

BUY
$73.37 - $98.18 $536,334 - $717,695
7,310 Added 175.34%
11,479 $1.13 Million
Q1 2020

Apr 08, 2020

SELL
$64.5 - $97.79 $6,127 - $9,290
-95 Reduced 2.23%
4,169 $318,000
Q4 2019

Jan 28, 2020

BUY
$72.13 - $90.25 $29,212 - $36,551
405 Added 10.49%
4,264 $378,000
Q3 2019

Oct 28, 2019

SELL
$62.98 - $75.72 $28,215 - $33,922
-448 Reduced 10.4%
3,859 $292,000
Q2 2019

Aug 08, 2019

BUY
$65.7 - $83.98 $328 - $419
5 Added 0.12%
4,307 $313,000
Q1 2019

May 01, 2019

SELL
$77.14 - $90.79 $25,379 - $29,869
-329 Reduced 7.1%
4,302 $347,000
Q4 2018

Jan 17, 2019

BUY
$77.85 - $96.01 $360,523 - $444,622
4,631 New
4,631 $427,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hotaling Investment Management, LLC Portfolio

Follow Hotaling Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hotaling Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hotaling Investment Management, LLC with notifications on news.